Fragment-based Drug Discovery

Global Market Trajectory & Analytics

MCP16405

EXECUTIVE ENGAGEMENTS

POOL

403
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

81
Interactions with Platform & by Email

PARTICIPANTS

16
Unique # Participated

VALIDATIONS

7
Responses Validated*

COMPANIES

44
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

102

PAGES

176

EDITION

9

PRICE

USD 4950

CODE

MCP16405


COMPETITIVE METRICS

COMPANY

D S N T

% *

Astex Pharmaceuticals, Inc.

Beactica AB

Charles River Laboratories International, Inc.

Crystax Pharmaceuticals

Nuevolution

Sprint Bioscience

Sygnature Discovery Ltd.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Fragment-based Drug Discovery estimated at US$568 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at aCAGR of 10.4% over the period 2020-2027. Fragment Screening Technique, one of the segments analyzed in the report, is projected to record 11% CAGR and reach US$644.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fragment Optimization Technique segment is readjusted to a revised 9.7% CAGR for the next 7-year period.
The Fragment-based Drug Discovery market in the U.S. is estimated at US$168.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$195.6 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

SELECT PLAYERS

Astex Pharmaceuticals, Inc.; Beactica AB; Charles River Laboratories International, Inc.; Evotec AG; Sygnature Discovery Ltd.

SEGMENTS

» End-Use (Biopharmaceutical Companies, Contract Research Organization, Academic and Research Institutions) » Service Type (Fragment Screening Technique, Fragment Optimization Technique)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Fragment-based Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Fragment-based Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Fragment-based Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Fragment Screening Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Fragment Screening Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Fragment Screening Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Fragment Optimization Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Fragment Optimization Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Fragment Optimization Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Research Organization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic and Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic and Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic and Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
China Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Fragment-based Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Fragment-based Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Fragment-based Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
France Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027
Total Companies Profiled: 44

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com